According to the expectations, there was a trend towards more APOE Σ4-carriers in the AD group than in the MCD group, with the prevalence of Σ4-carriers in the MCD group closely matching to the prevalence of over 30% in the Finnish population35. The gene discussed is APOE; the disease is Alzheimer disease.